Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
Despite differences in enrollment criteria, the baseline characteristics of the menopausal women with coronary heart disease enrolled in the cardiovascular outcome trials of menopausal hormone therapy or raloxifene are remarkably similar. Globally, cardiovascular risk factors were not optimally controlled at entry into these trials. More aggressive cardiovascular risk factor interventions are requisite to achieve optimal target goals for women with documented coronary heart disease.
Wenger
Nanette K
NK
Emory University School of Medicine, Atlanta, GA 30303, USA. mwenger@emory.edu
Geiger
Mary Jane
MJ
D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003920:Diabetes Mellitus / Q000453:epidemiology; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000453:epidemiology; D008055:Lipids / Q000097:blood; D008593:Menopause; D008875:Middle Aged; D018579:Patient Selection; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology
D000924:Anticholesteremic Agents; D008055:Lipids; D020849:Raloxifene Hydrochloride